Warm scene with two contrasting symbols: on the left a pancreas with immune cells for type 1, on the right a cell with blocked insulin action for type 2.
🥪
Type 1
Immune system
vs.
🔒
Type 2
Insulin resistance
Same name,
different cause
Two different diseases – with different treatment.
The common denominator is blood sugar that’s too high. But the paths there are fundamentally different: in type 1 insulin is almost entirely missing; in type 2 there’s enough, it just works poorly. That’s exactly what explains the different treatment.
Type 1: the immune system attacks insulin production
Evidence level: established
Type 1 diabetes is an autoimmune disease: the body’s own defences destroy the insulin-producing beta cells in the pancreas. The result is an absolute insulin deficiency – the body can barely produce its own insulin. Type 1 makes up about 5–10% of all diabetes cases, often begins in childhood or young adulthood, and usually appears fairly acutely with clear symptoms such as strong thirst, frequent urination and weight loss. Because there’s barely any insulin of one’s own, lifelong insulin therapy is necessary from the start.
Type 2: insulin works less well
Evidence level: established
In type 2 diabetes there’s initially enough insulin – but the cells respond to it less and less (insulin resistance). The pancreas compensates with extra work for a while, until it eventually can’t keep up (relative insulin deficiency). At about 90–95%, type 2 is by far the most common form, mostly affects adults and develops gradually over years – often without symptoms. It’s treated first through lifestyle (nutrition, movement) and, if needed, medications; sometimes insulin becomes necessary later.
Comparison table. Type 1: autoimmune destruction of the beta cells, absolute insulin deficiency, about 5 to 10 percent of cases, often young and acute onset, insulin always needed. Type 2: insulin resistance plus declining insulin production, about 90 to 95 percent, mostly adults and gradual onset, lifestyle and medication, sometimes insulin.
The direct comparison
Type 1
Type 2
Cause
Autoimmune: beta cellsare destroyed
Insulin resistance +declining production
Insulin
almost entirely missing
present, works poorly
Frequency
approx. 5–10%
approx. 90–95%
Onset
often young, acute
mostly adults, gradual
Treatment
always insulin
lifestyle, meds, sometimes insulin
Intermediate forms: LADA (slow type 1 in adults) and MODY (rare genetic form).
Why the distinction matters
The right classification determines treatment: type 1 always needs insulin – here it would be dangerous to rely on lifestyle alone. In type 2, by contrast, a lot can often be moved through nutrition, movement and weight, sometimes up to remission. The diagnosis is always made by medical professionals, using blood sugar, HbA1c, antibodies and C-peptide, among others.
Key takeaways
- Type 1: autoimmune, absolute insulin deficiency, ~5–10%, often young, acute, always insulin.
- Type 2: insulin resistance + relative deficiency, ~90–95%, mostly adults, gradual.
- Intermediate forms like LADA and MODY exist; C-peptide and antibodies help distinguish them.
- Treatment depends on the type – the diagnosis is always made by a doctor.
Sources
Sources as of: 21 Jul 2026.
- Type 1 vs. type 2: causes, frequency, onset and treatment. Diabinfo (German Diabetes Information Portal). diabinfo.de
- Type 1 diabetes: autoimmune destruction of beta cells, insulin therapy. IQWiG / Gesundheitsinformation. gesundheitsinformation.de
- Classification and diagnosis (antibodies, C-peptide, HbA1c); LADA/MODY. ADA Standards of Care. diabetesjournals.org